283 related articles for article (PubMed ID: 34939244)
1. Co-occurrence of gut microbiota dysbiosis and bile acid metabolism alteration is associated with psychological disorders in Crohn's disease.
Feng L; Zhou N; Li Z; Fu D; Guo Y; Gao X; Liu X
FASEB J; 2022 Jan; 36(1):e22100. PubMed ID: 34939244
[TBL] [Abstract][Full Text] [Related]
2. The impact of exclusive enteral nutrition on the gut microbiome and bile acid metabolism in pediatric Crohn's disease.
Lv Y; Lou Y; Liu A; Cheng Q; Yang G; Xu C; Luo Y; Lou J; Yu J; Fang Y; Zhao H; Peng K; Ni Y; Chen J
Clin Nutr; 2023 Feb; 42(2):116-128. PubMed ID: 36527826
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of Faecal Microbiota in Paediatric Crohn's Disease and Their Dynamic Changes During Infliximab Therapy.
Wang Y; Gao X; Ghozlane A; Hu H; Li X; Xiao Y; Li D; Yu G; Zhang T
J Crohns Colitis; 2018 Feb; 12(3):337-346. PubMed ID: 29194468
[TBL] [Abstract][Full Text] [Related]
4. Detection of Gut Dysbiosis due to Reduced Clostridium Subcluster XIVa Using the Fecal or Serum Bile Acid Profile.
Murakami M; Iwamoto J; Honda A; Tsuji T; Tamamushi M; Ueda H; Monma T; Konishi N; Yara S; Hirayama T; Miyazaki T; Saito Y; Ikegami T; Matsuzaki Y
Inflamm Bowel Dis; 2018 Apr; 24(5):1035-1044. PubMed ID: 29688473
[TBL] [Abstract][Full Text] [Related]
5. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
Takahashi K; Nishida A; Fujimoto T; Fujii M; Shioya M; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A
Digestion; 2016; 93(1):59-65. PubMed ID: 26789999
[TBL] [Abstract][Full Text] [Related]
6. Diet-induced remission in chronic enteropathy is associated with altered microbial community structure and synthesis of secondary bile acids.
Wang S; Martins R; Sullivan MC; Friedman ES; Misic AM; El-Fahmawi A; De Martinis ECP; O'Brien K; Chen Y; Bradley C; Zhang G; Berry ASF; Hunter CA; Baldassano RN; Rondeau MP; Beiting DP
Microbiome; 2019 Aug; 7(1):126. PubMed ID: 31472697
[TBL] [Abstract][Full Text] [Related]
7. Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome.
Wei W; Wang HF; Zhang Y; Zhang YL; Niu BY; Yao SK
World J Gastroenterol; 2020 Dec; 26(45):7153-7172. PubMed ID: 33362374
[TBL] [Abstract][Full Text] [Related]
8. Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn's disease.
Wang Y; Gao X; Zhang X; Xiao F; Hu H; Li X; Dong F; Sun M; Xiao Y; Ge T; Li D; Yu G; Liu Z; Zhang T
Gut Microbes; 2021; 13(1):1-18. PubMed ID: 33430702
[TBL] [Abstract][Full Text] [Related]
9. Gut Microbiota Dysbiosis Is Associated with Altered Bile Acid Metabolism in Infantile Cholestasis.
Wang Y; Gao X; Zhang X; Xiao Y; Huang J; Yu D; Li X; Hu H; Ge T; Li D; Zhang T
mSystems; 2019 Dec; 4(6):. PubMed ID: 31848302
[TBL] [Abstract][Full Text] [Related]
10. Hyperbaric oxygen therapy ameliorates intestinal and systematic inflammation by modulating dysbiosis of the gut microbiota in Crohn's disease.
Li Y; Sun R; Lai C; Liu K; Yang H; Peng Z; Xu D; Huang F; Tang K; Peng Y; Liu X
J Transl Med; 2024 May; 22(1):518. PubMed ID: 38816750
[TBL] [Abstract][Full Text] [Related]
11. Plasma bile acids in association with Crohn's disease.
Kiasat A; Prast-Nielsen S; Rautiainen S; Engstrand L; Andersson F; Lindberg J; Schuppe-Koistinen I; Löf Granström A; Gustafsson UO
Scand J Gastroenterol; 2024 Jun; 59(6):674-682. PubMed ID: 38505982
[TBL] [Abstract][Full Text] [Related]
12. Disease-Associated Gut Microbiota Reduces the Profile of Secondary Bile Acids in Pediatric Nonalcoholic Fatty Liver Disease.
Yu J; Zhang H; Chen L; Ruan Y; Chen Y; Liu Q
Front Cell Infect Microbiol; 2021; 11():698852. PubMed ID: 34568090
[TBL] [Abstract][Full Text] [Related]
13. The association between gut microbiota development and maturation of intestinal bile acid metabolism in the first 3 y of healthy Japanese infants.
Tanaka M; Sanefuji M; Morokuma S; Yoden M; Momoda R; Sonomoto K; Ogawa M; Kato K; Nakayama J
Gut Microbes; 2020; 11(2):205-216. PubMed ID: 31550982
[TBL] [Abstract][Full Text] [Related]
14. Fecal Microbiota Alterations Associated With Clinical and Endoscopic Response to Infliximab Therapy in Crohn's Disease.
Zhuang X; Tian Z; Feng R; Li M; Li T; Zhou G; Qiu Y; Chen B; He Y; Chen M; Zeng Z; Zhang S
Inflamm Bowel Dis; 2020 Oct; 26(11):1636-1647. PubMed ID: 33026078
[TBL] [Abstract][Full Text] [Related]
15. Impact of traditional Chinese medicine treatment on chronic unpredictable mild stress-induced depression-like behaviors: intestinal microbiota and gut microbiome function.
Qu W; Liu S; Zhang W; Zhu H; Tao Q; Wang H; Yan H
Food Funct; 2019 Sep; 10(9):5886-5897. PubMed ID: 31464319
[TBL] [Abstract][Full Text] [Related]
16. Traumatic Brain Injury Induces Gastrointestinal Dysfunction and Dysbiosis of Gut Microbiota Accompanied by Alterations of Bile Acid Profile.
You W; Zhu Y; Wei A; Du J; Wang Y; Zheng P; Tu M; Wang H; Wen L; Yang X
J Neurotrauma; 2022 Jan; 39(1-2):227-237. PubMed ID: 33677989
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease.
He C; Wang H; Liao WD; Peng C; Shu X; Zhu X; Zhu ZH
World J Gastroenterol; 2019 May; 25(18):2204-2216. PubMed ID: 31143071
[TBL] [Abstract][Full Text] [Related]
18. Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation.
Xu M; Cen M; Shen Y; Zhu Y; Cheng F; Tang L; Hu W; Dai N
Dig Dis Sci; 2021 Feb; 66(2):568-576. PubMed ID: 32198567
[TBL] [Abstract][Full Text] [Related]
19. The Impact of NOD2 Variants on Fecal Microbiota in Crohn's Disease and Controls Without Gastrointestinal Disease.
Kennedy NA; Lamb CA; Berry SH; Walker AW; Mansfield J; Parkes M; Simpkins R; Tremelling M; Nutland S; ; Parkhill J; Probert C; Hold GL; Lees CW
Inflamm Bowel Dis; 2018 Feb; 24(3):583-592. PubMed ID: 29462388
[TBL] [Abstract][Full Text] [Related]
20. Relationship between the gut microbiota and bile acid composition in the ileal mucosa of Crohn's disease.
Bamba S; Inatomi O; Nishida A; Ohno M; Imai T; Takahashi K; Naito Y; Iwamoto J; Honda A; Inohara N; Andoh A
Intest Res; 2022 Jul; 20(3):370-380. PubMed ID: 33975420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
